Triple
T33388725
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Seagen |
E854988
|
entity |
| Predicate | PadcevIndication |
P23162
|
FINISHED |
| Object | urothelial carcinoma |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: urothelial carcinoma | Statement: [Seagen, PadcevIndication, urothelial carcinoma]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: PadcevIndication Context triple: [Seagen, PadcevIndication, urothelial carcinoma]
-
A.
treatmentIndication
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
B.
isIndicatedAsMonotherapyFor
Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
-
C.
indicatedFor
chosen
Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
-
D.
indicationTestedIn
Indicates that a particular medical indication (disease or condition) has been evaluated or tested in a specified clinical study or experimental context.
-
E.
receivedUSFDAApprovalFor
Indicates that an entity has obtained official approval from the U.S. Food and Drug Administration (FDA) for a specific product, use, or application.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f3496d54048190a1cb91fdd7caa6ea |
completed | April 30, 2026, 12:22 p.m. |
| NER | Named-entity recognition | batch_69f6f38159d08190980ad639e08f00f4 |
completed | May 3, 2026, 7:04 a.m. |
| PD | Predicate disambiguation | batch_69f6e3d7bee48190b94e0beb48a1d7fa |
completed | May 3, 2026, 5:57 a.m. |
Created at: May 1, 2026, 1:35 a.m.